Lv7243
5005 积分 2021-05-28 加入
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial
1个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
1个月前
已完结
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
1个月前
已完结
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
1个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
1个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
1个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
1个月前
已完结
皖公网安备34019202002308
